WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, January 28, 2009, 29(4):918-929; doi:10.1523/JNEUROSCI.3952-08.2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in J. Neurosci.
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, Q.
Right arrow Articles by Wu, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, Q.
Right arrow Articles by Wu, J.

 Previous Article  |  Next Article 

Neurobiology of Disease
A Novel Nicotinic Acetylcholine Receptor Subtype in Basal Forebrain Cholinergic Neurons with High Sensitivity to Amyloid Peptides

Qiang Liu,1 Yao Huang,3 Fenqin Xue,2 Alain Simard,2 Jamie DeChon,1 Guohui Li,1 Jianliang Zhang,2 Linda Lucero,2 Min Wang,4 Michael Sierks,4 Gang Hu,5 Yongchang Chang,2 Ronald J. Lukas,2 and Jie Wu1

Divisions of 1Neurology and 2Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013-4496, 3Department of Obstetrics and Gynecology, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85004, 4Department of Chemical Engineering, Arizona State University, Tempe, Arizona 85281, and 5Department of Pharmacology, Nanjing Medical University, Nanjing 210029, People's Republic of China

Correspondence should be addressed to Dr. Jie Wu, Division of Neurology, Barrow Neurological Institute, 350 West Thomas Road, Phoenix, AZ 85013-4496. Email: jie.wu{at}chw.edu

Nicotinic acetylcholine receptors (nAChRs) containing {alpha}7 subunits are thought to assemble as homomers. {alpha}7-nAChR function has been implicated in learning and memory, and alterations of {alpha}7-nAChR have been found in patients with Alzheimer's disease (AD). Here we report findings consistent with a novel, naturally occurring nAChR subtype in rodent, basal forebrain cholinergic neurons. In these cells, {alpha}7 subunits are coexpressed, colocalize, and coassemble with β2 subunit(s). Compared with homomeric {alpha}7-nAChRs from ventral tegmental area neurons, functional, presumably heteromeric {alpha}7β2-nAChRs on cholinergic neurons freshly dissociated from medial septum/diagonal band (MS/DB) exhibit relatively slow kinetics of whole-cell current responses to nicotinic agonists and are more sensitive to the β2 subunit-containing nAChR-selective antagonist, dihydro-β-erythroidine (DHβE). Interestingly, presumed, heteromeric {alpha}7β2-nAChRs are highly sensitive to functional inhibition by pathologically relevant concentrations of oligomeric, but not monomeric or fibrillar, forms of amyloid β1–42 (Aβ1–42). Slow whole-cell current kinetics, sensitivity to DHβE, and specific antagonism by oligomeric Aβ1–42 also are characteristics of heteromeric {alpha}7β2-nAChRs, but not of homomeric {alpha}7-nAChRs, heterologously expressed in Xenopus oocytes. Moreover, choline-induced currents have faster kinetics and less sensitivity to Aβ when elicited from MS/DB neurons derived from nAChR β2 subunit knock-out mice rather than from wild-type mice. The presence of novel, functional, heteromeric {alpha}7β2-nAChRs on basal forebrain cholinergic neurons and their high sensitivity to blockade by low concentrations of oligomeric Aβ1–42 suggests possible mechanisms for deficits in cholinergic signaling that could occur early in the etiopathogenesis of AD and might be targeted by disease therapies.

Key words: nicotinic receptor; basal forebrain; cholinergic neurons; patch clamp; amyloid β; Alzheimer's disease


Received Aug. 19, 2008; revised Dec. 2, 2008; accepted Dec. 16, 2008.

Correspondence should be addressed to Dr. Jie Wu, Division of Neurology, Barrow Neurological Institute, 350 West Thomas Road, Phoenix, AZ 85013-4496. Email: jie.wu{at}chw.edu


Related articles in J. Neurosci.:

This Week in The Journal

J. Neurosci. 2009 29: i. [Full Text]  



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
G. Y. Lopez-Hernandez, J. S. Thinschmidt, G. Zheng, Z. Zhang, P. A. Crooks, L. P. Dwoskin, and R. L. Papke
Selective Inhibition of Acetylcholine-Evoked Responses of {alpha}7 Neuronal Nicotinic Acetylcholine Receptors by Novel tris- and tetrakis-Azaaromatic Quaternary Ammonium Antagonists
Mol. Pharmacol., September 1, 2009; 76(3): 652 - 666.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-